# Top 10 Life Science VC (Venture Capital) Funds in Italy in May 2026

## Sofinnova Partners
- Type: VC Fund
- Location: Paris, Ile-de-France, France
- Relevant deals: 4
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Medical

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

## Principia SGR
- Type: VC Fund
- Location: Milan, Lombardia, Italy
- Relevant deals: 2
- Stages: Series A, Seed
- Focus: Health Care, Biotechnology, Software

Principia is an Italian Venture Capital firm with over Eur 80M under management. Currently Principia has two funds investing in digital start ups and expansion capital opportunities and in particular cases, we invest also in seed opportunities.

## Indaco Venture Partners
- Type: VC Fund
- Location: Milan, Lombardia, Italy
- Relevant deals: 2
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

VENTURE We invest across all sectors with specific focus on technology and digital The largest independent more About Us Portfolio [...]

## JDRF T1D Fund
- Type: VC Fund
- Location: Boston, Massachusetts, United States
- Relevant deals: 1
- Stages: Series A, Series B
- Focus: Biotechnology, Health Care, Medical

The JDRF T1D Fund (www.t1dfund.org) is a venture philanthropy fund exclusively devoted to finding and funding the best early-stage T1D commercial opportunities to accelerate the delivery of treatments, preventions, and cures to patients. It was created to solve a critical funding gap in the T1D drug and device development pipeline. Throughpartnerships with private capital, including venture capital, pharma and foundations, the T1D Fund anticipates that it will be able to attract substantially more private investment to the T1D field than occurs today. The T1D Fund will initially focus on artificial pancreas systems, metabolic control, beta cell replacement, prevention, and beta cell restoration therapies, with an exclusive priority on the best commercial opportunities. The T1D Fund will reinvest any realized gains into new investments to further its mission.

## Italian Angels for Growth
- Type: VC Fund
- Location: Milan, Lombardia, Italy
- Relevant deals: 1
- Stages: Seed, Angel
- Focus: Software, E-Commerce, Health Care

IAG is an angel investor network that offers access to its affiliates to early-stage venture opportunities. Its members to date have deployed over 22 million Euros to support 41 startups in the series seed/series A stage in many verticals, among which: Medtech, SAAS, e-commerce, Fintech, and high tech at large. Every investment opportunityat IAG is vetted by a professional team together with expert members of the group. Once invested, the company receives the support of up to two Investment champions, who bring their expertise to the table and help them succeed.

## Claris Ventures
- Type: VC Fund
- Location: Torino, Piemonte, Italy
- Relevant deals: 1
- Stages: Series B, Series A, Seed
- Focus: Biotechnology, Medical, Biopharma

Claris Ventures is a venture capital firm supporting the best scientists in building successful life sciences companies that will impact people's lives

## Roche Venture Fund
- Type: VC Fund
- Location: Basel, Basel-Stadt, Switzerland
- Relevant deals: 1
- Stages: Series B, Series A, Series C
- Focus: Biotechnology, Health Care, Therapeutics

The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.

## Invitalia Ventures
- Type: VC Fund
- Location: Rome, Lazio, Italy
- Relevant deals: 1
- Stages: Series A, Seed
- Focus: Software, Medical, Health Care

Invitalia Ventures SGR manages the “Italia Venture Fund I”, a 87€/Ml sized co-investment fund that invests in early stage operations in Italy. They co-invest up to a maximum of 70% in round A (€ 0.5ML - € 1.5ML) in high growth sectors. Invitalia Ventures, with its network of co-investors not only provides risk capital, but also know-how and anetwork for business development. Main LPs includes the Ministery of Economic Development, the European Investment Bank, Cisco Group, the Sardinian Banking Foundation and Metec Group.They are looking for visionary entrepreneurs who share their passion for innovation.
Growth is their mission!!For more information please contact us at info@invitaliaventures.it or visit our website: www.invitaliaventures.it

## AbbVie Biotech Ventures
- Type: VC Fund
- Location: North Chicago, Illinois, United States
- Relevant deals: 1
- Stages: Series A, Series B, Series C
- Focus: Biotechnology, Health Care, Therapeutics

AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company's mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world's most complex and serious diseases. Togetherwith its wholly-owned subsidiary, Pharmacyclics, AbbVie employs ~29,000 people worldwide and markets medicines in more than 175 countries.

## Club degli Investitori
- Type: VC Fund
- Location: Torino, Piemonte, Italy
- Relevant deals: 1
- Stages: Seed, Series A
- Focus: E-Commerce, Health Care, Software

Club degli Investitori (Investors Club) is a network of investors and business angels that invest on early-stage SMEs and startups. The community of 300+ Members (entrepreneurs, CEOs, executive managers) actively scouts for investing opportunities on SMEs & startups and invests with a minimum ticket of €200k. The Club supports business byinvesting capital and by leveraging the Members' network and experience.Club degli Investitori is supported by Unicredit and KPMG Italy.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co